Tiglutik
My Prescription
Payment
Select pharmacy
$2,123.78
$30.00 due at pharmacy
$2,123.78 - $30.00 = $2,093.78
$2,093.78 remaining balance
You will be given your coupon after you complete your purchase with PayPal.
AlbertsonsPowered by$2,123.78
Print or send this coupon to your phone
AlbertsonsPowered byAbout Tiglutik
Drug Details
Riluzole, marketed as Rilutek, is a medication used to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. This drug helps to slow the progression of ALS symptoms and may extend the patient's survival by two to three months. Riluzole works by reducing the release of glutamate, a chemical that is believed to contribute to nerve damage in ALS. Although it does not improve existing symptoms, it may delay the need for a breathing tube. Riluzole is available in various forms, including a liquid and an oral film, to accommodate patients who have difficulty swallowing pills. Always consult your healthcare provider before starting any new medication to ensure it is safe and appropriate for your condition.
Price history for Tiglutik
1, 300ML of 50MG/10ML
Average retail price for Tiglutik
Average SaveHealth price for Tiglutik
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Tiglutik dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 300ML of 50MG/10ML | 1 Box | $2,123.78 | $2,123.78 |
| 300ML of 50MG/10ML | 2 Boxes | $4,239.55 | $2,119.78 |
| 300ML of 50MG/10ML | 3 Boxes | $6,355.33 | $2,118.44 |
Tiglutik FAQs
Tiglutik is used for the treatment of amyotrophic lateral sclerosis (ALS). It is a liquid formulation of riluzole, which helps to slow the progression of the disease and prolong survival or time to tracheostomy.
Rilutek and Tiglutik both contain the active ingredient riluzole, which is used to treat amyotrophic lateral sclerosis (ALS). The primary difference between the two is their formulation. Rilutek is available in tablet form, while Tiglutik is an oral suspension. This difference in formulation can affect how the medication is administered and may be chosen based on patient preference or specific medical needs.
Yes, Tiglutik is approved by the FDA. It is an oral suspension formulation of riluzole, used for the treatment of amyotrophic lateral sclerosis (ALS).
Tiglutik is used for the treatment of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. It is a formulation of riluzole in an oral suspension form, which can be easier for patients with difficulty swallowing.
The generic name for Tiglutik is riluzole.